News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SmartPill Diagnostics, Inc. Capsule Clinical Trials Are Set To Begin At The University of Louisville



10/19/2005 5:10:11 PM

BUFFALO, N.Y.--(BUSINESS WIRE)--May 12, 2005--The SmartPill Corporation (www.smartpillcorp.com), developer of the SmartPill Capsule, an ingestible medical device that captures biomedical data from within a patient's GI tract, today announced that clinical trials of its SmartPill ACT-I Capsule and GI Monitoring System are expected to begin the week of May 23rd at the University of Louisville (Louisville, KY), bringing to five the number of sites participating in SmartPill clinical trials. A total of 20 subjects, 14 Normals and six Gastroparetics, are expected to participate in the clinical research study. The principal investigator is John M. Wo, M.D., Associate Professor and Director of the Swallowing and Motility Center, and of the Clinical Research Unit, University of Louisville Department of Medicine, Division of Gastroenterology/Hepatology. The primary objective of the study is to demonstrate the correlation of gastric residence times measured by the SmartPill ACT-I Capsule and conventional scintigraphy.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES